Aquestive 制药

US · AQST #3650 按市值排名上市于 2018

3.78 -0.28 -6.90%

实时 - 追踪5344个代码 - 心跳于269秒前 · 2026-10-16 19:59

✦ 量化股权信号计算方式说明

增持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例上升了0.3个百分点。

机构持股

机构持股比例: 58.26% +0.26pp
机构数量: 206 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund27.55%

Hedge Fund12.59%

Family Office/Trust7.85%

Public Company4.19%

Individual/Insider2.77%

VC/PE Fund2.74%

Private Company2.35%

Insurance Company0.79%

Government Pension Fund0.21%

Other38.96%

主要股东截至 2026-06-30

Bratton Capital Management, L.P. 7.82% · 9.81M 股

BlackRock 6.43% · 8.07M 股

RTW Investments, LP 5.92% · 7.43M 股

Vanguard Capital Management, LLC 4.17% · 5.24M 股

Federated Hermes, Inc. 2.48% · 3.11M 股

State Street Global Advisors 2.33% · 2.93M 股

Geode Capital Management, LLC 2.09% · 2.62M 股

Samsara BioCapital LLC 1.99% · 2.50M 股

Bank of America Corporation 1.33% · 1.67M 股

Sio Capital Management, LLC 1.18% · 1.49M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 25次买入 · 24次卖出

姓名	职务	持股比例
Daniel Barber	Chief Executive Officer	0.52%
Stephen Wargacki	Senior VP of Research & Development	0.27%
Peter Boyd	Senior Vice President of IT, HR & Communications	0.23%
A. Toth	Chief Financial Officer	0.23%
Carl Kraus	Chief Medical Officer	0.23%
Melina Cioffi	Senior Vice President of Regulatory Affairs	0.22%
Sherry Korczynski	Officer	0.19%
Lori Braender	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary	0.18%
Douglas Bratton	Former Independent Director	0.17%
Cassie Jung	Officer	0.17%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-14	Daniel Barber	Chief Executive Officer	Open Market Disposition	-25,000	$4.82
2026-09-08	Peter Boyd	Senior Vice President of IT, HR & Communications	Derivative Exercise and Retained	+2,293	$0.96
2026-09-08	Sherry Korczynski	Officer	Derivative Exercise and Sale	-8,750	$2.65–5.22
2026-09-07	Daniel Barber	Chief Executive Officer	Derivative Exercise and Retained	+91,743	$0.96
2026-09-02	Cassie Jung	Officer	Derivative Exercise and Retained	+4,587	$0.96
2026-08-16	Daniel Barber	Chief Executive Officer	Open Market Disposition	-25,000	$4.29
2026-08-13	Sherry Korczynski	Officer	Sale to Issuer	-2,714	$4.25
2026-07-15	Daniel Barber	Chief Executive Officer	Open Market Disposition	-25,000	$4.00–4.03
2026-07-14	Daniel Barber	Chief Executive Officer	Intent to Sell (Form 144)	-25,000	$4.04
2026-06-22	Julie Krop	Independent Director	Derivative Exercise and Sale	-25,000	$0.71–5.02
2026-06-14	Daniel Barber	Chief Executive Officer	Open Market Disposition	-25,000	$4.16
2026-06-09	Timothy Morris	Independent Director	Other Derivative Acquisition	+50,500	$3.99
2026-06-09	Gregory Brown	Independent Director	Other Derivative Acquisition	+50,500	$3.99
2026-06-09	Julie Krop	Independent Director	Other Derivative Acquisition	+50,500	$3.99
2026-06-09	John Cochran	Independent Vice Chairperson	Other Derivative Acquisition	+50,500	$3.99
2026-06-09	Marco Taglietti	Independent Director	Other Derivative Acquisition	+50,500	$3.99
2026-06-09	Abigail Jenkins	Independent Director	Other Derivative Acquisition	+50,500	$3.99
2026-06-07	Sherry Korczynski	Officer	Sale to Issuer	-2,714	--
2026-05-17	Thomas Zalewski	Chief Legal Officer & Chief Compliance Officer	Other Acquisition	+100,000	--
2026-05-17	Thomas Zalewski	Chief Legal Officer & Chief Compliance Officer	Other Derivative Acquisition	+75,000	$4.14

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:59:43 · 仅供参考，不构成投资建议，也未考虑您的具体情况。